Financhill
Sell
17

IMRX Quote, Financials, Valuation and Earnings

Last price:
$4.64
Seasonality move :
1.9%
Day range:
$4.62 - $5.05
52-week range:
$1.10 - $10.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
323.21x
P/B ratio:
1.31x
Volume:
1M
Avg. volume:
2.6M
1-year change:
138.66%
Market cap:
$299M
Revenue:
--
EPS (TTM):
-$1.78

Earnings Data

Next earnings date for IMRX
Mar 19
2026
Most recent earnings per share
-$0.38
Beat by $0.01
(Nov 12/2025)
Consensus Estimate
-$0.39
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.35 --
03/19/2026 Q4 -- -- -- -$0.31 --
11/12/2025 Q3 -- -- -$0.38 -$0.39 $0.01
08/13/2025 Q2 -- -- -$0.40 -$0.40 -$0.00
05/06/2025 Q1 -- -- -$0.42 -$0.59 $0.16
03/20/2025 Q4 -- -- -$0.58 -$0.45 -$0.14
11/13/2024 Q3 -- -- -$0.49 -$0.55 $0.06
08/06/2024 Q2 -- -- -$0.47 -$0.53 $0.05
05/07/2024 Q1 -- -- -$0.49 -$0.50 $0.02
03/01/2024 Q4 -- -- -$0.52 -$0.48 -$0.04
11/09/2023 Q3 -- -- -$0.43 -$0.49 $0.06
08/03/2023 Q2 -- -- -$0.43 -- --
05/04/2023 Q1 -- -- -$0.51 -- --
03/06/2023 Q4 -- $500 -$0.50 -- --
11/10/2022 Q3 -- $38.4K -$0.49 -- --
08/10/2022 Q2 -- $94.4K -$0.44 -- --
05/10/2022 Q1 -- $183.7K -$0.49 -- --
03/10/2022 Q4 -- $189.6K -$0.41 -- --
11/09/2021 Q3 -- $482.1K -$0.33 -- --
09/09/2021 Q2 -- $660K -$0.31 -- --
03/31/2021 Q1 -- $748.2K -$0.24 -- --
12/31/2020 Q4 -- $665.1K -$0.23 -- --
09/30/2020 Q3 -- $682.6K -$0.17 -- --
06/30/2020 Q2 -- $480.8K -$0.14 -- --
03/31/2020 Q1 -- $483K -$0.13 -- --

Immuneering Corp. Earnings Questions

  • How Much did Immuneering Corp. Generate in Revenue Last Quarter?

    Immuneering Corp. reported -- worth of top line sales in its most recent quarter.

  • Did Immuneering Corp. Beat Earnings Last Quarter?

    Immuneering Corp. announced earnings per share of -$0.38 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Immuneering Corp. Profitable?

    Immuneering Corp. reported -$86.2K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Immuneering Corp. EPS Next Year?

    Immuneering Corp.'s earnings are forecast to decrease from -$2.04 per share to -$1.42 per share next year representing a decrease of -28.2%.

  • When is Immuneering Corp.'s Earnings Date?

    Immuneering Corp.'s next earnings date is March 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Sell
50
Is GOOGL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Alerts

Sell
40
GDXU alert for Jan 31

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.

Sell
34
PFSI alert for Jan 31

PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.

Buy
60
JNUG alert for Jan 31

Direxion Daily Junior Gold Miners Idx Bull 2X Shs [JNUG] is down 26.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock